In Other Journals

Ann Gregory
Med J Aust 2004; 180 (7): . || doi: 10.5694/j.1326-5377.2004.tb05959.x
Published online: 5 April 2004

Scandinavian researchers have pulled the plug on their own trial, HABITS (hormonal replacement therapy after breast cancer — is it safe?).1 An interim safety analysis found that breast cancer survivors allocated to receive 2 years of hormone replacement therapy (HRT) for menopausal symptoms were experiencing an "unacceptably high risk" of breast cancer compared with those allocated to best symptomatic treatment without hormones (26/174 v 7/171; relative hazard 3.5). Any participants currently receiving HRT were advised to discontinue. An accompanying commentary said that the HABITS finding was consistent with those from the Women’s Health Initiative (WHI) trial.2

  • Ann Gregory



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.